Te-Sheng Chang

DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation

Ssu-Chuan Lai, Yu-Ting Su, Ching‐Chi Chi et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 128 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis

Te-Sheng Chang, Yu-Chih Wu, Shui‐Yi Tung et al. · The American Journal of Gastroenterology · 2015 · 127 citations

Medicine, Oncology, Cancer Screening +16

Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression

Te-Sheng Chang, Yu-Chih Wu, Ching‐Chi Chi et al. · Clinical Cancer Research · 2015 · 96 citations · Full text

Medicine, Cancer Biology, Oncology +17

Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma

Te-Sheng Chang, Chi‐Long Chen, Yu-Chih Wu et al. · PLoS ONE · 2016 · 46 citations · Full text

Medicine, Cancer Biology, Oncology +17

TGF-βI Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis

Heng-Kien Au, Jui-Hung Chang, Yu-Chih Wu et al. · PLoS ONE · 2015 · 36 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +8